Jeff Lagasse
The J&J scientists said that out of 75,000 participants in a clinical trial, there was just one case of cerebral venous sinus thrombosis.
While none are officially FDA approved, the agency has cleared them under emergency use authorization.
Round 2 is a $249.95 million federal initiative that builds on the $200 million program established as part of the CARES Act.
The signees view the lack of a second application period as a hindrance to the move toward value-based care.
Revenues, profit and earnings per share all saw increases both month-over-month and year-over-year.
Average seller size by revenue was $676 million, well above historical averages for the first quarter and for recent year-end averages.
Vaccine opposition at a social media event inspired the creation of new guidelines to combat misinformation.
The pandemic has acted as an accelerant for the development and evolution of these technologies.
The goal of the partnership is to enhance care by enabling members to receive certain healthcare services in their homes.
Many beneficiaries with end-stage kidney disease suffer from poor health outcomes and face increased risk of complications.